Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
Description
The Montreal Cognitive Assessment (MoCA) is a concise, 30-item evaluation designed for healthcare professionals to identify cognitive deficits at an early stage, facilitating quicker diagnoses and enhanced patient management. This tool enables both healthcare providers and researchers to recognize cognitive challenges associated with various conditions, including Alzheimer's disease, Parkinson's disease, and several others such as frontotemporal dementia and brain tumors. MoCA is frequently utilized by a diverse range of practitioners, including nurses, primary care doctors, specialists, occupational therapists, and psychologists, among others. It efficiently evaluates critical cognitive functions such as short-term memory, visuospatial skills, executive functioning, attention, and language abilities, as well as orientation to time and place. The versatility of MoCA makes it an essential component of cognitive health assessments across various settings.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
$20 per month
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
Yes
Android App
Yes
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Vendor Details
Company Name
MoCA Cognition
Founded
1996
Country
Canada
Website
mocacognition.com